Loganic acid [22255-40-9]

Référence T6S1440-25mg

Conditionnement : 25mg

Marque : TargetMol


Loganic acid (Synonyms: Loganate)

Loganic acid

Copy Product Info
Synonyms Loganate
Loganic acid
Cas No. 22255-40-9
For research use only—not for human use. No sales to individuals. Use as intended only.
Select Batch
Purity:99.45%
Color:White to Yellow
COA HNMR LCMS

Product Introduction

Loganic acid AI Summary
Loganic acid exhibits antiviral activity against HCV by inhibiting viral entry and replication in human Huh7 cells, with inhibition percentages of 39.4% and 52.5% at different time points, and an IC50 value of 11.0 µg/mL in inhibiting viral replication after 72 hours by NS5A staining. Additionally, this compound shows significant inhibitory activity in both OATP1B1 and OATP1B3-transfected CHO cells, with 49.18% inhibition of sodium fluorescein uptake in OATP1B1 cells and 99.49% inhibition in OATP1B3 cells at a concentration of 10 µM. Furthermore, Loganic acid exhibits inhibitory activity on both COX1 and COX2 enzymes, showing moderate inhibition of COX1 with percentages between 36.0% and 36.9% at 10 µM and 35 µM concentrations, and potent inhibition of COX2 with inhibition percentages between 80.8% and 84.0% at the same concentrations, though this activity significantly decreases to ≤30.0% at 100 µM. These characteristics suggest that Loganic acid has multifaceted bioactivity with potential applications in antiviral therapy and enzyme inhibition..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
1. Loganic acid (Loganate) and geniposide exhibit both sides effect on superoxide generation.
SynonymsLoganate
Chemical Properties
Molecular Weight376.36
FormulaC16H24O10
Cas No.22255-40-9
Smiles19[C@]12C[C@H](O)[C@H](C)[C@@]1(19)[C@H](O[C@]1(19)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)OC=C2C(O)=O
Relative Density.1.6g/cm3
Storage & Solubility Information
StorageShipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 250 mg/mL (664.26 mM), Sonication is recommended.
Ethanol: Soluble
Pyridine, Methanol, etc.: Soluble
H2O: 1 g/mL, Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.31 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.6570 mL13.2852 mL26.5703 mL132.8515 mL
5 mM0.5314 mL2.6570 mL5.3141 mL26.5703 mL
10 mM0.2657 mL1.3285 mL2.6570 mL13.2852 mL
20 mM0.1329 mL0.6643 mL1.3285 mL6.6426 mL
50 mM0.0531 mL0.2657 mL0.5314 mL2.6570 mL
100 mM0.0266 mL0.1329 mL0.2657 mL1.3285 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.